CytoDyn (CYDY) Current Assets (2009 - 2026)
CytoDyn (CYDY) recorded Current Assets of $18.98 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), up 42.2% from $13.35 million a year earlier and up 36.8% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn reported Current Assets of $13.88 million, down 22.4% from FY2025.
- Annual Current Assets has a five-year compound annual growth rate of -17.4% (FY2021 to FY2026).
- Across earlier fiscal years, Current Assets came in at $17.88 million in FY2025 (+65.3%), $10.82 million in FY2024 (+0.1%), $10.81 million in FY2023 (+2.8%) and $10.52 million in FY2022 (-70.9%).
- The fiscal Q1 2027 figure is the highest quarterly Current Assets since fiscal Q3 2025.
- On a year-over-year basis, Current Assets rose in four of the last eight quarters, with growth averaging 30.9%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 178.7% in fiscal Q2 2025, against a decline of 93.6% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $13.88 million (Q4 2026), $18.44 million (Q3 2026) and $8.84 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 18.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 18.98 Mn |
| May 31, 2026 | 13.88 Mn |
| Feb 28, 2026 | 18.44 Mn |
| Nov 30, 2025 | 8.84 Mn |
| Aug 31, 2025 | 13.35 Mn |
| May 31, 2025 | 17.88 Mn |
| Feb 28, 2025 | 20.98 Mn |
| Nov 30, 2024 | 24.63 Mn |
| Aug 31, 2024 | 27.74 Mn |
| May 31, 2024 | 10.82 Mn |
| Feb 29, 2024 | 9.91 Mn |
| Nov 30, 2023 | 8.84 Mn |
| Aug 31, 2023 | 11.97 Mn |
| May 31, 2023 | 10.81 Mn |
| Feb 28, 2023 | 14.11 Mn |
| Nov 30, 2022 | 6.55 Mn |
| Aug 31, 2022 | 9.86 Mn |
| May 31, 2022 | 10.52 Mn |
| Feb 28, 2022 | 92.35 Mn |
| Nov 30, 2021 | 101.81 Mn |
API Access
CytoDyn Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();